PUBLISHER: Industry Experts | PRODUCT CODE: 1057439
PUBLISHER: Industry Experts | PRODUCT CODE: 1057439
The COVID-19 pandemic that struck the world towards end-2019 and beginning-2020 left a telling adverse impact on several sectors, though the Sleeping Aids market was able to maintain some semblance of equanimity. One of the most critical outcomes of the pandemic was the widespread announcement of lockdowns across the globe, due to which people were compelled to work from home and several individuals also lost their jobs, as companies resorted to cost-cutting measures to maintain some level of profitability in business. These factors have played a crucial in altering what can be called the human psyche, leading to more and more events of insomnia/sleeplessness among people.
Disorders in sleep can have serious consequences for a person's health, safety and quality of life, along with playing havoc with cognitive wellbeing. A number of sleep disorders have been identified and researched upon, the prominent ones among which include insomnia, sleep apnea, restless legs syndrome, narcolepsy and sleepwalking. The growing prevalence of such conditions has been instrumental in propelling the demand for Sleeping Aids products and services, which comprise Mattresses & Pillows, Medications, Sleep Apnea Devices and Sleep Laboratories. Medications is estimated the largest product type of Sleeping Aids market in 2021 worth US$26.6 billion and forecast to be US$28.4 billion in 2022.
The market for key product types of Sleeping Aids studied in this report comprise the following:
The report analyzes the market for the following major sleep disorders:
This report reviews, analyzes and projects the global Sleeping Aids market for the period 2018-2027 in terms of market value in US$ and the compound annual growth rates (CAGRs) projected from 2022 through 2027.